Efficacy and Safety of Glucagon‐Like Peptide‐1 Receptor Agonists Following Bariatric Surgery: A Systematic Review and Meta‐Analysis
GLP-1RAs significantly reduce weight, BMI, HbA1c, and total cholesterol in patients following bariatric surgery. These findings highlight the potential of GLP-1RA therapy post-bariatric surgery. Future research is warranted to assess the long-term effects of GLP-1RA on the post-operative metabolic profile.
Authors
- Hateem Gaba
- Abdur Raheem Bilal
- Abdur Rafay Bilal (ORCID: https://orcid.org/0009-0007-4236-7520)
- Shaheer Qureshi
- Rahul Balach
- R Ahmed
- Saad Ahmed Waqas
- S. M. Washaqul Arfin
- Muhammad Ibrahim
- Peter Collins
Institutions
- Dow University of Health Sciences (PK)
- Imperial College London (GB)
- Ziauddin University (PK)
Publication Details
- Journal
- Endocrinology Diabetes & Metabolism
- Published
- 2026-02-21
- DOI
- https://doi.org/10.1002/edm2.70102
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00